Landiolol, an ultra-short-acting β1-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis

Podobne zapisy

• Dose-Dependent Effect of Landiolol, a New Ultra-Short-Acting β(1)-Blocker, on Supraventricular Tachyarrhythmias in Postoperative Patients
  od: Taenaka, Nobuyuki, i wsp.
  Wydane: (2013)
• The Effectiveness and Safety of Landiolol Hydrochloride, an Ultra-Short-Acting β(1)-Blocker, in Postoperative Patients with Supraventricular Tachyarrhythmias: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
  od: Taenaka, Nobuyuki, i wsp.
  Wydane: (2013)
• Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction
  od: Wada, Yuko, i wsp.
  Wydane: (2016)
• Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study
  od: Matsuda, Naoyuki, i wsp.
  Wydane: (2020)
• Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia
  od: Kiuchi, Shunsuke, i wsp.
  Wydane: (2017)